当前位置:首页 - 行情中心 - 科源制药(301281) - 财务分析 - 现金流量表

科源制药

(301281)

  

流通市值:23.13亿  总市值:36.39亿
流通股本:6885.20万   总股本:1.08亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金142,475,971.3174,220,714.67349,761,602.41253,258,899.75
  收到的税费返还566,215.2522,182.282,073,299.311,742,746.79
  收到其他与经营活动有关的现金8,842,411.236,288,440.4815,369,166.6116,651,386.41
  经营活动现金流入小计151,884,597.7980,531,337.43367,204,068.33271,653,032.95
  购买商品、接受劳务支付的现金33,748,514.3420,683,350.2122,399,011.2473,046,785.98
  支付给职工以及为职工支付的现金59,518,351.9228,971,217.58106,384,021.8379,891,039.47
  支付的各项税费11,657,301.622,336,969.5821,206,659.4322,732,994.47
  支付其他与经营活动有关的现金21,390,650.429,091,948.73177,730,159.7872,111,296.47
  经营活动现金流出小计126,314,818.2881,083,486.09427,719,852.28247,782,116.39
  经营活动产生的现金流量净额25,569,779.51-552,148.66-60,515,783.9523,870,916.56
二、投资活动产生的现金流量:
  收回投资收到的现金443,020,967.55164,958,298.82964,972,007.19859,298,332.19
  取得投资收益收到的现金1,872,579.95933,567.045,554,774.162,484,402.67
  处置固定资产、无形资产和其他长期资产收回的现金净额15,318-95,480.8895,590
  收到的其他与投资活动有关的现金-13,200,000--
  投资活动现金流入小计444,908,865.5179,091,865.86970,622,262.23861,878,324.86
  购建固定资产、无形资产和其他长期资产支付的现金90,982,620.5636,389,183.93296,384,404.53214,098,877.21
  投资支付的现金292,262,295.25179,497,084.2859,751,690.65695,792,476.33
  取得子公司及其他营业单位支付的现金--1,656,835.31,656,835.3
  支付其他与投资活动有关的现金--407,131.57-
  投资活动现金流出小计383,244,915.81215,886,268.131,158,200,062.05911,548,188.84
  投资活动产生的现金流量净额61,663,949.69-36,794,402.27-187,577,799.82-49,669,863.98
三、筹资活动产生的现金流量:
  吸收投资收到的现金--1,000,0001,000,000
  其中:子公司吸收少数股东投资收到的现金--1,000,0001,000,000
  取得借款收到的现金53,617,376.0821,005,121.4345,621,608.17-
  收到其他与筹资活动有关的现金--1,010,347.43-
  筹资活动现金流入小计53,617,376.0821,005,121.4347,631,955.61,000,000
  偿还债务支付的现金3,478,384.98---
  分配股利、利润或偿付利息支付的现金21,664,494.54-32,562,968.6632,487,820.72
  支付其他与筹资活动有关的现金-5,558,296.7--
  筹资活动现金流出小计25,142,879.525,558,296.732,562,968.6632,487,820.72
  筹资活动产生的现金流量净额28,474,496.5615,446,824.7315,068,986.94-31,487,820.72
四、汇率变动对现金及现金等价物的影响513,591.9415,142.81585,250.5381,826.89
五、现金及现金等价物净增加额116,221,817.66-21,484,583.39-232,439,346.33-56,904,941.25
  加:期初现金及现金等价物余额91,769,768.2191,742,381.91324,209,114.54324,209,114.54
  期末现金及现金等价物余额207,991,585.8770,257,798.5291,769,768.21267,304,173.29
补充资料:
  净利润42,641,961.6-60,271,862.25-
  资产减值准备1,351,026.66-8,940,549.44-
  固定资产和投资性房地产折旧22,409,934.29-41,397,505.43-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧22,409,934.29-41,397,505.43-
  无形资产摊销3,125,198.95-5,462,695.16-
  长期待摊费用摊销146,029.14-384,546.64-
  处置固定资产、无形资产和其他长期资产的损失---77,957.39-
  固定资产报废损失38,829.6-922,441.69-
  公允价值变动损失-50,958.9--795,000-
  财务费用-497,021.26--548,655.5-
  投资损失-69,714.93--12,142,743.09-
  递延所得税-1,541,444.62-391,431.32-
  其中:递延所得税资产减少-245,182.58--133,216.97-
    递延所得税负债增加-1,296,262.04-524,648.29-
  存货的减少-18,602,539.91--28,465,486.08-
  经营性应收项目的减少-14,143,846.76--162,934,593.17-
  经营性应付项目的增加-9,237,674.35-26,677,619.35-
  现金的期末余额207,991,585.87-91,769,768.21-
  减:现金的期初余额91,769,768.21-324,209,114.54-
  现金及现金等价物的净增加额116,221,817.66--232,439,346.33-
公告日期2025-08-162025-04-252025-04-112024-10-25
审计意见(境内)标准无保留意见
TOP↑